一公司官网变黑白

Core Viewpoint - The sudden passing of Mr. Yin Zhenglong, the controlling shareholder, actual controller, and chairman of the company, has raised concerns about the future leadership and management of the company [1][3]. Company Overview - Anhui Shanhe Pharmaceutical Excipients Co., Ltd. was established in April 2001 and specializes in the production, research and development, and sales of new pharmaceutical excipients [6]. - The company is a leading player in the domestic pharmaceutical excipients (solid preparations) industry and was listed on the Shenzhen Stock Exchange's Growth Enterprise Market in May 2015 under the stock code 300452 [6]. - The company has a registered capital of 180.46707 million RMB and operates subsidiaries including Qufu Tianli Pharmaceutical Excipients Co., Ltd. (controlling) and Hefei Shanhe Pharmaceutical Technology Co., Ltd. (wholly-owned) [6]. Leadership Transition - Mr. Yin Zhenglong held 63,057,454 shares, accounting for 26.90% of the company's total shares, making him the controlling shareholder and actual controller [3]. - Following Mr. Yin's passing, the company announced that the board of directors would not fall below the legal number of members, ensuring normal operations [3]. - The company’s management team will continue to perform their duties, and the board will expedite the election of a new chairman [3]. - Mr. Song Daocai, a board member and general manager, has been temporarily appointed to fulfill the duties of chairman and legal representative until a new chairman is elected [3].